RIC vs. MAC followed by allogeneic stem cell transplantation for patients with MDS or secondary AML: A prospective, randomized phase III study of the CMWP of the EBMT (RICMAC-Trial)
Author(s):
Kroger, N.; Brand, R. (0000-0002-9596-4579); Niederwieser, D.; Platzbecker, U.; Hubel, K.; Weber, T.; Robin, M.; Stelljes, M.; Afanasiev, B.; Heim, D.; Deliliers, G.L.; Onida, F.; Dreger, P.; Pini, M.; Guidi, S.; Volin, L.; Gramatzki, M.; Bethge, W.; Poire, X.; Kobbe, G.; Os, M. van; Iacobelli, S.; Witte, T. de; Chronic Malignancies Working Party
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-03-31
Language
English
Is part of
Bone Marrow Transplantation (2015), Vol. 50, p. S5-S5
